In addition, recent evidence suggests IDH-Mut gliomas induce systemic effects on the immune system.72 These effects likely mediate immune suppression and may even have the potential to serve as biomarkers to predict the molecular subtype of the tumor, yet peripheral effects have not been characterized at the single-cell level and represent an important future direction. This evidence concerns the gene IDH1 and neoplasm.